Novozymes Financial Statements
Novozymes Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Novozymes Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 1,468.3 | 1,203.3 | 994.9 |
| Gross Profit ($ mil.) | 1,014.4 | 839.2 | 699.8 |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | 206.9 | 160.8 | 135.9 |
| Diluted EPS (Net Income) | -- | -- | -- |
Novozymes Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 3.94 | 0.87 | 7.01 |
| Price/Earnings Ratio | 28.82 | 72.99 | 25.51 |
| Price/Book Ratio | 8.02 | 2.49 | 6.74 |
| Price/Cash Flow Ratio | 14.95 | 8.05 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Novozymes Financial Ratios
